Author:
Chandrani P.,Prabhash K.,Prasad R.,Sethunath V.,Ranjan M.,Iyer P.,Aich J.,Dhamne H.,Iyer D.N.,Upadhyay P.,Mohanty B.,Chandna P.,Kumar R.,Joshi A.,Noronha V.,Patil V.,Ramaswamy A.,Karpe A.,Thorat R.,Chaudhari P.,Ingle A.,Choughule A.,Dutt A.
Funder
Wellcome Trust
Wellcome Trust/Department of Biotechnology India Alliance
Department of Biotechnology, Government of India
intramural
Reference39 articles.
1. Cancer Facts & Figures 2012;Society,2012
2. Biomarkers (BM) France: Results of routine EGFR, HER2, KRAS, BRAF, PI3KCA mutations detection and EML4-ALK gene fusion assessment on the first 10,000 non-small cell lung cancer (NSCLC) patients (pts);Barlesi;J Clin Oncol,2013
3. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs;Kris;JAMA,2014
4. Scientific advances in lung cancer 2015;Tsao;J Thorac Oncol,2016
5. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas;Campbell;Nat Genet,2016
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献